As the U.S. stock market experiences fluctuations, with tech stocks under pressure after a strong start to the week, investors are keenly observing opportunities for growth amid broader economic developments. For those interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain a relevant investment area. These stocks can offer affordability and growth potential when backed by strong financials, and this article will explore several examples that stand out for their financial strength and potential long-term value.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Rewards & Risks |
| Dingdong (Cayman) (DDL) | $1.81 | $357.89M | ✅ 4 ⚠️ 0 View Analysis > |
| Waterdrop (WDH) | $1.66 | $578.66M | ✅ 4 ⚠️ 0 View Analysis > |
| WM Technology (MAPS) | $0.985 | $164.35M | ✅ 4 ⚠️ 3 View Analysis > |
| LexinFintech Holdings (LX) | $4.25 | $720.17M | ✅ 4 ⚠️ 2 View Analysis > |
| Global Self Storage (SELF) | $4.98 | $56.46M | ✅ 3 ⚠️ 3 View Analysis > |
| Performance Shipping (PSHG) | $2.15 | $25.73M | ✅ 4 ⚠️ 2 View Analysis > |
| CI&T (CINT) | $4.53 | $590.99M | ✅ 4 ⚠️ 0 View Analysis > |
| Cricut (CRCT) | $4.78 | $1.01B | ✅ 2 ⚠️ 3 View Analysis > |
| BAB (BABB) | $0.8811 | $6.46M | ✅ 2 ⚠️ 3 View Analysis > |
| Lifetime Brands (LCUT) | $3.22 | $69.33M | ✅ 3 ⚠️ 2 View Analysis > |
Click here to see the full list of 359 stocks from our US Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Nano Dimension (NNDM)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Nano Dimension Ltd., along with its subsidiaries, offers industrial manufacturing solutions for electronics and mechanical parts across various regions including the Americas, Asia Pacific, Europe, the Middle East, and Africa, with a market cap of $355.93 million.
Operations: The company generates revenue from its Printers & Related Products segment, totaling $69.66 million.
Market Cap: $355.93M
Nano Dimension Ltd. is navigating a challenging phase, marked by leadership changes and strategic evaluations aimed at maximizing shareholder value. Despite being unprofitable with earnings declining by 4.6% annually over five years, the company maintains robust short-term assets of $657.3 million against liabilities and holds more cash than debt, ensuring financial stability. Recent partnerships highlight its innovative 3D printing capabilities in aerospace applications, potentially enhancing revenue streams. The appointment of a seasoned CFO and CEO suggests a focus on fiscal responsibility and growth opportunities within digital manufacturing sectors, supported by new financial advisors to explore strategic alternatives.
- Click here to discover the nuances of Nano Dimension with our detailed analytical financial health report.
- Gain insights into Nano Dimension's past trends and performance with our report on the company's historical track record.
MoneyHero (MNY)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: MoneyHero Limited operates a personal finance aggregation and comparison platform for banking, insurance, and other financial products, with a market cap of $53.27 million.
Operations: The company's revenue is primarily derived from its operations in Hong Kong ($29.66 million), Singapore ($25.78 million), the Philippines ($9.40 million), and Taiwan ($4.12 million).
Market Cap: $53.27M
MoneyHero Limited, with a market cap of US$53.27 million, is advancing its AI-driven transformation strategy through Project Odyssey to enhance revenue growth and operating margins. Despite past unprofitability and volatile share prices, the company recently reported its first quarterly net profit in Q2 2025, driven by improved conversions in key financial product verticals. The firm boasts strong short-term assets of US$74.3 million against minimal liabilities and remains debt-free, underscoring financial resilience. With an experienced CFO now at the helm and AI initiatives underway, MoneyHero aims for scalable profitability while maintaining a focus on operational efficiency.
- Dive into the specifics of MoneyHero here with our thorough balance sheet health report.
- Review our growth performance report to gain insights into MoneyHero's future.
Stereotaxis (STXS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for interventional laboratories globally with a market cap of $254.09 million.
Operations: The company's revenue is derived from its Surgical & Medical Equipment segment, totaling $31.81 million.
Market Cap: $254.09M
Stereotaxis, Inc., with a market cap of US$254.09 million, is making strides in the medical robotics field despite being currently unprofitable. Recent FDA clearance for its GenesisX™ robotic system and CE Mark approval for Synchrony™ highlight its innovative advancements in surgical technology. The company remains debt-free and has secured additional capital through a US$50 million equity offering to support growth initiatives. While analysts forecast revenue growth at 33.38% annually, Stereotaxis faces challenges with profitability not expected in the near term. Its experienced management and board provide stability as it navigates expansion efforts globally.
- Navigate through the intricacies of Stereotaxis with our comprehensive balance sheet health report here.
- Examine Stereotaxis' earnings growth report to understand how analysts expect it to perform.
Seize The Opportunity
- Click through to start exploring the rest of the 356 US Penny Stocks now.
- Interested In Other Possibilities? This technology could replace computers: discover the 28 stocks are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if MoneyHero might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com